ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,344Medicare Part D Prescriptions Filled, Including Refills

Rank: 88 out of 680

$1.01M Total Retail Price of All Prescriptions

Rank: 79 out of 680

664 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 664 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

16% of this provider’s 664 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 13,561 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LISINOPRIL 614 461 1 5
LEVOTHYROXINE SODIUM 522 461 2 2
AMLODIPINE BESYLATE 515 458 3 1
NAMENDA 468 459 4 35
SIMVASTATIN 415 391 5 3
OMEPRAZOLE 382 319 6 7
FUROSEMIDE 374 335 7 6
HYDROCODONE-ACETAMINOPHEN 358 221 S3 8 4
METOPROLOL TARTRATE 306 234 9 12
DONEPEZIL HCL 271 262 10 27
RISPERIDONE 221 209 11 80
METFORMIN HCL 209 172 12 8
PANTOPRAZOLE SODIUM 204 162 13 30
FAMOTIDINE 202 155 14 89
POTASSIUM CHLORIDE 197 163 15 14
HYDRALAZINE HCL 195 161 16 71
CITALOPRAM HBR 192 158 17 22
POLYETHYLENE GLYCOL 3350 189 167 18 62
JANTOVEN 181 179 19 147
EXELON 178 177 20 112
MELOXICAM 171 147 21 24
CLONIDINE HCL 171 104 21 36
CARVEDILOL 166 143 23 23
SERTRALINE HCL 165 145 24 28
QUETIAPINE FUMARATE 164 142 25 64
PRAVASTATIN SODIUM 164 109 25 10
ISOSORBIDE MONONITRATE ER 156 131 27 59
TAMSULOSIN HCL 152 143 28 34
METOCLOPRAMIDE HCL 151 107 29 118
GABAPENTIN 145 107 30 15
KLOR-CON M20 138 119 31 61
CARBIDOPA-LEVODOPA 137 137 32 117
WARFARIN SODIUM 136 107 33 20
GLIMEPIRIDE 129 106 34 29
CLOPIDOGREL 128 120 35 26
MIRTAZAPINE 127 112 36 78
ATORVASTATIN CALCIUM 127 104 36 11
HYDROCHLOROTHIAZIDE 123 104 38 9
TRAZODONE HCL 116 99 39 48
MEGESTROL ACETATE 114 91 R 40 88
NEXIUM 107 94 41 16
CIPROFLOXACIN HCL 106 77 42 57
SANTYL 105 95 43 170
DIGOXIN 104 85 44 58
PHENYTOIN SODIUM EXTENDED 102 54 45 115
PLAVIX 102 91 45 39
ESCITALOPRAM OXALATE 100 84 47 45
METOPROLOL SUCCINATE 99 81 48 13
NIFEDIPINE ER 95 83 49 75
PREDNISONE 86 64 50 50
BUMETANIDE 85 84 51 102
CYMBALTA 85 64 51 46
ATENOLOL 85 83 51 19
KLOR-CON M10 85 83 51 127
BACLOFEN 84 41 55 140
AMITRIPTYLINE HCL 81 46 R 56 47
DOXYCYCLINE HYCLATE 81 63 56 95
ACTOS 79 79 58 114
AMIODARONE HCL 76 62 59 158
DIVALPROEX SODIUM 73 55 60 110
SULFAMETHOXAZOLE-TRIMETHOPRIM 67 59 61 94
NITROFURANTOIN MONO-MACRO 67 61 61 172
OXYBUTYNIN CHLORIDE ER 65 65 63 143
AZITHROMYCIN 63 56 64 42
DIOVAN 61 58 65 31
LEVETIRACETAM 58 36 66 120
ALLOPURINOL 58 46 66 33
VALPROIC ACID 58 30 66 254
TRAMADOL HCL 57 43 69 18
SUCRALFATE 57 53 69 160
ALENDRONATE SODIUM 57 57 69 32
LOSARTAN POTASSIUM 56 42 72 21
LACTULOSE 56 52 72 92
SEROQUEL 55 49 74 123
ZOLPIDEM TARTRATE 54 45 75 17
OXYBUTYNIN CHLORIDE 53 50 76 129
FINASTERIDE 53 52 76 109
RANITIDINE HCL 51 50 78 56
JANUVIA 51 40 78 60
SINGULAIR 50 35 80 91
ZETIA 50 35 80 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 30, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.